Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence
Executive Summary
Cardinal Health expects to market its own generic version of Bristol-Myers Squibb's cardiac imaging agent Cardiolite (technetium Tc99m sestamibi) as part of a plan to expand its role in the generic sector
You may also be interested in...
Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt
The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20
Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt
The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20
Teva Anticipates “Major Consolidation” In Generic Industry In 2005
Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco